China's anti Ebola drug "jk-05" is expected to be put into Africa in batches

In recent days, the Ebola epidemic in West Africa seems to be showing no signs of improvement, and concerns about the global spread of the Ebola epidemic are increasing China played an important role in the battle against Ebola: on August 10, China sent public health experts to Liberia, Sierra Leone, Guinea and other countries with serious Ebola epidemic; on August 29, the drug "jk-05" developed by China for Ebola virus passed the expert review of the Ministry of health of the Ministry of general logistics and obtained the approval documents of special drugs for the army; 8 On December 31, media reported that jk-05 would be put into the epidemic area of West Africa in batches to help control the local epidemic It is reported that "jk-05", developed by the Academy of Military Medical Sciences for five years, is a small molecule chemical drug, which can selectively inhibit the RNA polymerase of Ebola virus, so as to achieve the purpose of inhibiting virus replication The results show that the drug has the activity of anti Ebola virus in cell and animal level infection test Experts especially stressed that although the drug has completed preclinical research and completed the clinical safety evaluation when it is applicable to broad-spectrum anti influenza, the treatment of Ebola haemorrhagic fever is still limited to emergency use On August 31, media reported that jk-05 would be put into the epidemic area of West Africa in batches to help control the local epidemic However, people close to the Academy of Military Medical Sciences said there was "no way to confirm" the news But in any case, Chinese new drugs will bring new hope to fight the Ebola epidemic According to the latest report of the Ebola epidemic released by who on August 28, 3069 people have been infected in Guinea, Liberia, Sierra Leone and Nigeria, 1552 of whom have died In addition, the number of confirmed cases of Ebola virus infection in DRC has increased to six Who said the past week has seen the largest increase in cases since the outbreak, with evidence that the Ebola epidemic is "deteriorating." Since there is no effective treatment or vaccine for Ebola in the world, many countries and institutions began to consider the use of experimental drugs to prevent the spread of the epidemic The World Health Organization agreed earlier this month that it is in line with medical ethics to provide unconfirmed drugs or vaccines as potential treatment or prevention means in the current Ebola epidemic in West Africa At present, zmapp, an experimental drug developed by MAPP biopharmaceutical company in the United States, has both success and failure after trial in Ebola patients.